Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
12.00
+0.53 (+4.62%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
July 07, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
June 30, 2026
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END
Via
FinancialNewsMedia
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
June 30, 2026
Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity
From
MarketNewsUpdates.com
Via
GlobeNewswire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways Elects Kathleen Tregoning to Board of Directors
May 28, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
May 26, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
↗
May 21, 2026
Compass Pathways (NASDAQ:CMPS) executives said the company remains on track to target a fourth-quarter New Drug Application filing for COMP360, its synthetic psilocybin treatment candidate for...
Via
MarketBeat
Topics
Cannabis
Government
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
May 14, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass (CMPS) Q1 2026 Earnings Transcript
↗
May 13, 2026
Compass (CMPS) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Earnings
Compass Pathways Q1 Earnings Call Highlights
↗
May 13, 2026
Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for...
Via
MarketBeat
Topics
Cannabis
Earnings
Government
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights
May 13, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026
May 06, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2026
From
Compass Pathfinder Limited
Via
Business Wire
These 3 Psychedelic Stocks Activated After Trump's Executive Order
↗
April 27, 2026
Via
MarketBeat
Topics
Government
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
April 24, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Trump Backs Psychedelics. Here's 1 Company Investors Need to Know About
↗
April 23, 2026
Compass Pathways is already in the final stage of development on a psychedelic medicine to treat depression.
Via
The Motley Fool
Topics
Government
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
April 21, 2026
From
Compass Pathfinder Limited
Via
Business Wire
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up
↗
April 21, 2026
Via
Chartmill
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
April 20, 2026
Via
AB Newswire
This 4/20, Wall Street Is Betting on More Than Marijuana
↗
April 20, 2026
Via
MarketBeat
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session.
↗
April 20, 2026
Via
Chartmill
This Psychedelic Biotech Stock Is Soaring After Trump Executive Order
↗
April 20, 2026
COMPASS Pathways PLC (NASDAQ:CMPS) shares are soaring on Monday after President Donald Trump issued an executive order directing federal health agencies to speed up the review process for...
Via
Benzinga
Topics
Government
What's going on in today's session
↗
April 20, 2026
Via
Chartmill
Why Compass Pathways Stock Rocketed 40% Today
↗
April 20, 2026
Compass Pathways may be the first to benefit from an accelerated approval process.
Via
The Motley Fool
Topics
Government
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
↗
April 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders.
Via
The Motley Fool
Topics
Government
These stocks are gapping in today's session
↗
April 20, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 20, 2026
Via
Chartmill
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
April 20, 2026
From
Compass Pathfinder Limited
Via
Business Wire
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
April 18, 2026
From
Compass Pathfinder Limited
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
